Antidepressant drugs in anxiety disorders
- PMID: 3314359
- DOI: 10.1111/j.1600-0447.1987.tb07749.x
Antidepressant drugs in anxiety disorders
Abstract
The efficacy of tricyclic antidepressants and monoamine oxidase inhibitors (MAOI) in the treatment of panic syndromes (panic disorder and agoraphobia with panic attacks) and obsessive-compulsive disorders is reviewed. Imipramine has been reported as significantly more effective against panic attacks than placebo or other psychoactive drugs in 12 of 16 studies. Clomipramine has been found superior to placebo or other psychoactive drugs in 5 controlled studies. The effectiveness of these drugs is also reflected in a large number of open trials. The MAOI phenelzine has been reported to be effective in 5 controlled studies. Clomipramine is the best documented drug in the treatment of obsessive-compulsive disorders. Its effectiveness has been documented in 7 controlled studies. Most investigators consider the effects in panic syndromes as well as in obsessive-compulsive disorders to be unrelated to the antidepressant effect.
Similar articles
-
Antidepressants in the treatment of agoraphobia and obsessive-compulsive disorder.Compr Psychiatry. 1983 May-Jun;24(3):278-84. doi: 10.1016/0010-440x(83)90080-9. Compr Psychiatry. 1983. PMID: 6347516 Review. No abstract available.
-
Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia.J Clin Psychopharmacol. 1982 Dec;2(6):399-407. J Clin Psychopharmacol. 1982. PMID: 7174863
-
Pharmacologic treatment of anxiety disorders.J Clin Psychiatry. 1982 Dec;43(12):487-91. J Clin Psychiatry. 1982. PMID: 6131065 Review.
-
Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder.Drugs. 1990 Jan;39(1):136-53. doi: 10.2165/00003495-199039010-00010. Drugs. 1990. PMID: 2178909 Review.
-
Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.J Clin Psychiatry. 1985 Oct;46(10 Pt 2):6-24. J Clin Psychiatry. 1985. PMID: 3900056 Review.
Cited by
-
Alpha 1- and beta-adrenoceptor stimulation potentiate the anticonflict effect of a benzodiazepine.J Neural Transm Gen Sect. 1990;79(3):155-67. doi: 10.1007/BF01245127. J Neural Transm Gen Sect. 1990. PMID: 2153389
-
Effects of centrally administered neuropeptide Y (NPY) and NPY13-36 on the brain monoaminergic systems of the rat.J Neural Transm Gen Sect. 1990;79(3):193-208. doi: 10.1007/BF01245130. J Neural Transm Gen Sect. 1990. PMID: 2297403
-
MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study.Psychopharmacology (Berl). 1993;112(4):483-9. doi: 10.1007/BF02244898. Psychopharmacology (Berl). 1993. PMID: 7871061 Clinical Trial.
-
The utility of the panic disorder concept.Eur Arch Psychiatry Neurol Sci. 1989;238(5-6):268-79. doi: 10.1007/BF00449808. Eur Arch Psychiatry Neurol Sci. 1989. PMID: 2670574 Review.